semaxanib-resistant FLT3 mutants don't bind semaxanib<br>

Stable Identifier
R-HSA-9702578
Type
Reaction [transition]
Species
Homo sapiens
Compartment
plasma membrane
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
semaxanib-resistant FLT3 mutants don't bind semaxanib<br>
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The following FLT3 mutants are resistant to inhibition by semaxanib:

FLT3 D835N (partial: Bagrintseva et al, 2005)
FLT3 D835Y (partial: Bagrintseva et al, 2005)
Literature References
PubMed ID Title Journal Year
15626738 FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L)

Ellwart, JW, Reindl, C, Spiekermann, K, Geisenhof, S, Kern, R, Bagrintseva, K, Hiddemann, W, Eichenlaub, S

Blood 2005
Participants
Input
Participates
as an event of
Normal reaction
FLT3 binds type I TKI (Homo sapiens)
Functional status

Loss of function of semaxanib-resistant FLT3 mutants [plasma membrane]

Normal Entity
Disease Entity
Status
Disease
Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Authored
Rothfels, K  (2020-11-06)
Reviewed
Kazi, JU  (2020-11-06)
Created
Rothfels, K  (2020-10-01)
Cite Us!